Loading organizations...

§ Private Profile · Sherbrooke, QC, Canada
Cranial implants and prostheses for neurosurgery, improving outcomes for traumatic brain injury and stroke patients with single-procedure solutions.
Based in Sherbrooke, Quebec, EncephalX is a medical device company that develops cranial implants and prostheses for neurosurgery patients suffering from traumatic brain injuries and strokes. The company's primary product, the Dynamic Cranioplasty System, is designed to replace traditional two-step surgical interventions with a single-procedure solution aimed at reducing complications and hospital stays. In January 2026, the enterprise secured CAD 2.25 million in an oversubscribed pre-seed funding round to finance its first human implantation and upcoming regulatory submissions. This recent financing was led by ACET Capital, with additional participation from institutional and angel investors including Investissement Québec, Anges Québec, and Halo Health, Inc. The capital will also support the organization's planned international expansion across North American and European healthcare markets by the end of 2026. EncephalX was originally founded in 2020 by Simon Lapointe.
EncephalX has raised $2.6M across 2 funding rounds.
EncephalX has raised $2.6M in total across 2 funding rounds.
EncephalX has raised $2.6M across 2 funding rounds. Most recently, it raised $1.6M Pre-Seed in January 2026.
| Date | Round | Lead Investors | Other Investors | Status |
|---|---|---|---|---|
| Jan 27, 2026 | $1.6M Pre Seed | Dominic Denis | Louis Georges GUY, Luke Sheen, Alex Laverdière | Announced |
| Dec 19, 2023 | $1M Seed | Dominic Denis, Martine Courtemanche | Emmanuelle Coppinger | Announced |
EncephalX has raised $2.6M in total across 2 funding rounds.
EncephalX's investors include Dominic Denis, Louis-Georges Guy, Luke Sheen, Alex Laverdière, Martine Courtemanche, Emmanuelle Coppinger.